Beyond Imatinib: The Critical Role of Sunitinib Malate in GIST Second-Line Therapy Gastrointestinal Stromal Tumor Treatment: Sunitinib Malate's Role in Second-Line Therapy and Market Evolution
Introduction
Gastrointestinal stromal tumors, commonly known as GISTs, represent the most prevalent mesenchymal tumors of the gastrointestinal tract, though they remain relatively rare in the broader context of all cancer diagnoses. What makes GISTs clinically and commercially...
0 Поделились
82 Просмотры
0 предпросмотр